The global Blood Plasma Derivatives market was valued at US$ 30890 million in 2023 and is anticipated to reach US$ 47030 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

Blood Plasma Derivatives Market

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.

Report Scope

The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Plasma Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Blood Plasma Derivatives Market Report

Report Metric	Details
Report Name	Blood Plasma Derivatives Market
Accounted market size in 2023	US$ 30890 million
Forecasted market size in 2030	US$ 47030 million
CAGR	5.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Albumin Factor VIII Factor IX Immunoglobulin Hyperimmune Globulin Others
Segment by Application	Hospitals Clinics Other End Users
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG, CSL Limited, Takeda, China Biologic Products, Kedrion Biopharma, BDI Pharma, Bayer AG, Hualan Biological Engineering
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Derivatives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Plasma Derivatives Market growing?

Ans: The Blood Plasma Derivatives Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the Blood Plasma Derivatives Market size in 2030?

Ans: The Blood Plasma Derivatives Market size in 2030 will be US$ 47030 million.

Who are the main players in the Blood Plasma Derivatives Market report?

Ans: The main players in the Blood Plasma Derivatives Market are Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG, CSL Limited, Takeda, China Biologic Products, Kedrion Biopharma, BDI Pharma, Bayer AG, Hualan Biological Engineering

What are the Application segmentation covered in the Blood Plasma Derivatives Market report?

Ans: The Applications covered in the Blood Plasma Derivatives Market report are Hospitals, Clinics, Other End Users

What are the Type segmentation covered in the Blood Plasma Derivatives Market report?

Ans: The Types covered in the Blood Plasma Derivatives Market report are Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Albumin

1.2.3 Factor VIII

1.2.4 Factor IX

1.2.5 Immunoglobulin

1.2.6 Hyperimmune Globulin

1.2.7 Others

1.3 Market by Application

1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other End Users

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood Plasma Derivatives Market Perspective (2019-2030)

2.2 Blood Plasma Derivatives Growth Trends by Region

2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2019-2024)

2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2025-2030)

2.3 Blood Plasma Derivatives Market Dynamics

2.3.1 Blood Plasma Derivatives Industry Trends

2.3.2 Blood Plasma Derivatives Market Drivers

2.3.3 Blood Plasma Derivatives Market Challenges

2.3.4 Blood Plasma Derivatives Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood Plasma Derivatives Players by Revenue

3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2019-2024)

3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2019-2024)

3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue

3.4 Global Blood Plasma Derivatives Market Concentration Ratio

3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2023

3.5 Blood Plasma Derivatives Key Players Head office and Area Served

3.6 Key Players Blood Plasma Derivatives Product Solution and Service

3.7 Date of Enter into Blood Plasma Derivatives Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Plasma Derivatives Breakdown Data by Type

4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2019-2024)

4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2025-2030)

5 Blood Plasma Derivatives Breakdown Data by Application

5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2019-2024)

5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Blood Plasma Derivatives Market Size (2019-2030)

6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Blood Plasma Derivatives Market Size by Country (2019-2024)

6.4 North America Blood Plasma Derivatives Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood Plasma Derivatives Market Size (2019-2030)

7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Blood Plasma Derivatives Market Size by Country (2019-2024)

7.4 Europe Blood Plasma Derivatives Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2019-2030)

8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2019-2024)

8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Blood Plasma Derivatives Market Size (2019-2030)

9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Blood Plasma Derivatives Market Size by Country (2019-2024)

9.4 Latin America Blood Plasma Derivatives Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2019-2030)

10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2019-2024)

10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Grifols

11.1.1 Grifols Company Detail

11.1.2 Grifols Business Overview

11.1.3 Grifols Blood Plasma Derivatives Introduction

11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2019-2024)

11.1.5 Grifols Recent Development

11.2 SK Plasma

11.2.1 SK Plasma Company Detail

11.2.2 SK Plasma Business Overview

11.2.3 SK Plasma Blood Plasma Derivatives Introduction

11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2019-2024)

11.2.5 SK Plasma Recent Development

11.3 Fusion Health Care

11.3.1 Fusion Health Care Company Detail

11.3.2 Fusion Health Care Business Overview

11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction

11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2019-2024)

11.3.5 Fusion Health Care Recent Development

11.4 Biotest AG

11.4.1 Biotest AG Company Detail

11.4.2 Biotest AG Business Overview

11.4.3 Biotest AG Blood Plasma Derivatives Introduction

11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2019-2024)

11.4.5 Biotest AG Recent Development

11.5 Green Cross Corporation

11.5.1 Green Cross Corporation Company Detail

11.5.2 Green Cross Corporation Business Overview

11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction

11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2019-2024)

11.5.5 Green Cross Corporation Recent Development

11.6 Baxter International

11.6.1 Baxter International Company Detail

11.6.2 Baxter International Business Overview

11.6.3 Baxter International Blood Plasma Derivatives Introduction

11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2019-2024)

11.6.5 Baxter International Recent Development

11.7 LFB

11.7.1 LFB Company Detail

11.7.2 LFB Business Overview

11.7.3 LFB Blood Plasma Derivatives Introduction

11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2019-2024)

11.7.5 LFB Recent Development

11.8 Octapharma AG

11.8.1 Octapharma AG Company Detail

11.8.2 Octapharma AG Business Overview

11.8.3 Octapharma AG Blood Plasma Derivatives Introduction

11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2019-2024)

11.8.5 Octapharma AG Recent Development

11.9 CSL Limited

11.9.1 CSL Limited Company Detail

11.9.2 CSL Limited Business Overview

11.9.3 CSL Limited Blood Plasma Derivatives Introduction

11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2019-2024)

11.9.5 CSL Limited Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Blood Plasma Derivatives Introduction

11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2019-2024)

11.10.5 Takeda Recent Development

11.11 China Biologic Products

11.11.1 China Biologic Products Company Detail

11.11.2 China Biologic Products Business Overview

11.11.3 China Biologic Products Blood Plasma Derivatives Introduction

11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2019-2024)

11.11.5 China Biologic Products Recent Development

11.12 Kedrion Biopharma

11.12.1 Kedrion Biopharma Company Detail

11.12.2 Kedrion Biopharma Business Overview

11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction

11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2019-2024)

11.12.5 Kedrion Biopharma Recent Development

11.13 BDI Pharma

11.13.1 BDI Pharma Company Detail

11.13.2 BDI Pharma Business Overview

11.13.3 BDI Pharma Blood Plasma Derivatives Introduction

11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2019-2024)

11.13.5 BDI Pharma Recent Development

11.14 Bayer AG

11.14.1 Bayer AG Company Detail

11.14.2 Bayer AG Business Overview

11.14.3 Bayer AG Blood Plasma Derivatives Introduction

11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2019-2024)

11.14.5 Bayer AG Recent Development

11.15 Hualan Biological Engineering

11.15.1 Hualan Biological Engineering Company Detail

11.15.2 Hualan Biological Engineering Business Overview

11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction

11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2019-2024)

11.15.5 Hualan Biological Engineering Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Fusion Health Care

Biotest

Green Cross Corporation

China Biologic Products

Kedrion Biopharma

BDI Pharma

Bayer

Hualan Biological Engineering

Grifols

Grifols S A

SK Plasma

List of Tables

Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Albumin

Table 3. Key Players of Factor VIII

Table 4. Key Players of Factor IX

Table 5. Key Players of Immunoglobulin

Table 6. Key Players of Hyperimmune Globulin

Table 7. Key Players of Others

Table 8. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Blood Plasma Derivatives Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Blood Plasma Derivatives Market Share by Region (2019-2024)

Table 12. Global Blood Plasma Derivatives Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Blood Plasma Derivatives Market Share by Region (2025-2030)

Table 14. Blood Plasma Derivatives Market Trends

Table 15. Blood Plasma Derivatives Market Drivers

Table 16. Blood Plasma Derivatives Market Challenges

Table 17. Blood Plasma Derivatives Market Restraints

Table 18. Global Blood Plasma Derivatives Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Blood Plasma Derivatives Market Share by Players (2019-2024)

Table 20. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)

Table 21. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Blood Plasma Derivatives Product Solution and Service

Table 25. Date of Enter into Blood Plasma Derivatives Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Blood Plasma Derivatives Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2019-2024)

Table 29. Global Blood Plasma Derivatives Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Blood Plasma Derivatives Revenue Market Share by Type (2025-2030)

Table 31. Global Blood Plasma Derivatives Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2019-2024)

Table 33. Global Blood Plasma Derivatives Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2025-2030)

Table 35. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)

Table 50. Grifols Company Detail

Table 51. Grifols Business Overview

Table 52. Grifols Blood Plasma Derivatives Product

Table 53. Grifols Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 54. Grifols Recent Development

Table 55. SK Plasma Company Detail

Table 56. SK Plasma Business Overview

Table 57. SK Plasma Blood Plasma Derivatives Product

Table 58. SK Plasma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 59. SK Plasma Recent Development

Table 60. Fusion Health Care Company Detail

Table 61. Fusion Health Care Business Overview

Table 62. Fusion Health Care Blood Plasma Derivatives Product

Table 63. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 64. Fusion Health Care Recent Development

Table 65. Biotest AG Company Detail

Table 66. Biotest AG Business Overview

Table 67. Biotest AG Blood Plasma Derivatives Product

Table 68. Biotest AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 69. Biotest AG Recent Development

Table 70. Green Cross Corporation Company Detail

Table 71. Green Cross Corporation Business Overview

Table 72. Green Cross Corporation Blood Plasma Derivatives Product

Table 73. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 74. Green Cross Corporation Recent Development

Table 75. Baxter International Company Detail

Table 76. Baxter International Business Overview

Table 77. Baxter International Blood Plasma Derivatives Product

Table 78. Baxter International Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 79. Baxter International Recent Development

Table 80. LFB Company Detail

Table 81. LFB Business Overview

Table 82. LFB Blood Plasma Derivatives Product

Table 83. LFB Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 84. LFB Recent Development

Table 85. Octapharma AG Company Detail

Table 86. Octapharma AG Business Overview

Table 87. Octapharma AG Blood Plasma Derivatives Product

Table 88. Octapharma AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 89. Octapharma AG Recent Development

Table 90. CSL Limited Company Detail

Table 91. CSL Limited Business Overview

Table 92. CSL Limited Blood Plasma Derivatives Product

Table 93. CSL Limited Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 94. CSL Limited Recent Development

Table 95. Takeda Company Detail

Table 96. Takeda Business Overview

Table 97. Takeda Blood Plasma Derivatives Product

Table 98. Takeda Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 99. Takeda Recent Development

Table 100. China Biologic Products Company Detail

Table 101. China Biologic Products Business Overview

Table 102. China Biologic Products Blood Plasma Derivatives Product

Table 103. China Biologic Products Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 104. China Biologic Products Recent Development

Table 105. Kedrion Biopharma Company Detail

Table 106. Kedrion Biopharma Business Overview

Table 107. Kedrion Biopharma Blood Plasma Derivatives Product

Table 108. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 109. Kedrion Biopharma Recent Development

Table 110. BDI Pharma Company Detail

Table 111. BDI Pharma Business Overview

Table 112. BDI Pharma Blood Plasma Derivatives Product

Table 113. BDI Pharma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 114. BDI Pharma Recent Development

Table 115. Bayer AG Company Detail

Table 116. Bayer AG Business Overview

Table 117. Bayer AG Blood Plasma Derivatives Product

Table 118. Bayer AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 119. Bayer AG Recent Development

Table 120. Hualan Biological Engineering Company Detail

Table 121. Hualan Biological Engineering Business Overview

Table 122. Hualan Biological Engineering Blood Plasma Derivatives Product

Table 123. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)

Table 124. Hualan Biological Engineering Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Blood Plasma Derivatives Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Blood Plasma Derivatives Market Share by Type: 2023 VS 2030

Figure 3. Albumin Features

Figure 4. Factor VIII Features

Figure 5. Factor IX Features

Figure 6. Immunoglobulin Features

Figure 7. Hyperimmune Globulin Features

Figure 8. Others Features

Figure 9. Global Blood Plasma Derivatives Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Blood Plasma Derivatives Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Other End Users Case Studies

Figure 14. Blood Plasma Derivatives Report Years Considered

Figure 15. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Blood Plasma Derivatives Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Blood Plasma Derivatives Market Share by Region: 2023 VS 2030

Figure 18. Global Blood Plasma Derivatives Market Share by Players in 2023

Figure 19. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2023

Figure 21. North America Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Blood Plasma Derivatives Market Share by Country (2019-2030)

Figure 23. United States Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Blood Plasma Derivatives Market Share by Country (2019-2030)

Figure 27. Germany Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2019-2030)

Figure 35. China Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Blood Plasma Derivatives Market Share by Country (2019-2030)

Figure 43. Mexico Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2019-2030)

Figure 47. Turkey Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 50. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 51. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 52. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 53. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 54. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 55. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 56. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 57. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 58. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 59. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 60. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 61. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 62. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 63. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions